Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd (SHE:301130)

China flag China · Delayed Price · Currency is CNY
26.31
+0.36 (1.39%)
Jun 12, 2026, 3:04 PM CST
Market Cap1.99B -6.7%
Revenue (ttm)238.55M -1.4%
Net Income22.79M -34.0%
EPS0.30 -32.9%
Shares Out 75.49M
PE Ratio87.15
Forward PEn/a
Dividend0.26 (0.99%)
Ex-Dividend DateJun 1, 2026
Volume891,620
Open26.80
Previous Close25.95
Day's Range25.70 - 26.80
52-Week Range25.42 - 36.98
Beta0.45
Analystsn/a
Price Targetn/a
Earnings DateAug 14, 2026

About SHE:301130

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd engages in the research and development, production, and sales of chemical raw materials and pharmaceutical preparations in China. The company provides drugs for the treatment of anemia, mental disorders, anti-psychotic disorders, cardiovascular and cerebrovascular diseases, and tumors. It provides drugs in the form of tablets and capsules. The company was founded in 1990 and is headquartered in Panshi, China. [Read more]

Sector Healthcare
Founded 1990
Employees 320
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301130
Full Company Profile

Financial Performance

In 2025, SHE:301130's revenue was 234.84 million, a decrease of -8.41% compared to the previous year's 256.41 million. Earnings were 21.90 million, a decrease of -45.62%.

Financial Statements